First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

BACKGROUND: An ongoing phase 3 study of the efficacy, safety, and immunogenicity of candidate malaria vaccine RTS,S/AS01 is being conducted in seven African countries. METHODS: From March 2009 through January 2011, we enrolled 15,460 children in two age categories--6 to 12 weeks of age and 5 to 17 m...

Повний опис

Бібліографічні деталі
Автори:	Agnandji, S, Lell, B, Soulanoudjingar, S, Fernandes, J, Abossolo, B, Conzelmann, C, Methogo, BG, Doucka, Y, Flamen, A, Mordmüller, B, Issifou, S, Kremsner, P, Sacarlal, J, Aide, P, Lanaspa, M, Aponte, J, Nhamuave, A, Quelhas, D, Bassat, Q, Mandjate, S, Macete, E, Alonso, P, Abdulla, S, Salim, N, Juma, O
Формат:	Journal article
Мова:	English
Опубліковано:	2011

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

Схожі ресурси